Lecture: HBV drug resistance

There are two stages of viral mutations that lead to drug resistance. The first stage produces viral quasispecies that are not particularly fit for robust replication.  An example of this is the well-known YMDD mutation.  A second mutation, termed a compensatory mutation, occurs when this first mutation gives rise to a mutant strain that replicates more effectively.

The recognized risk factors for the development of drug resistant HBV strains include: high pre-treatment viral load, prior exposure to the medication, and longer duration of treatment.

So, now you know what it is and why it happens, but how do you detect it?  Monitor viral loads every 3 to 6 months and look out for the following: biochemical breakthrough (ALT > 2x ULN), flare (ALT > 10x ULN), virologic breakthrough (> 1 log rise) and rebound (VL > 20,000 IU/mL).  Be skeptical about patient non-compliance with the drug regimen when this happens.

This entry was posted in Lecture. Bookmark the permalink.

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s